404 related articles for article (PubMed ID: 29069865)
1. S100A4 in cancer progression and metastasis: A systematic review.
Fei F; Qu J; Zhang M; Li Y; Zhang S
Oncotarget; 2017 Sep; 8(42):73219-73239. PubMed ID: 29069865
[TBL] [Abstract][Full Text] [Related]
2. Role of metastasis-induced protein S100A4 in human non-tumor pathophysiologies.
Fei F; Qu J; Li C; Wang X; Li Y; Zhang S
Cell Biosci; 2017; 7():64. PubMed ID: 29204268
[TBL] [Abstract][Full Text] [Related]
3. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
4. S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation.
Hua T; Liu S; Xin X; Cai L; Shi R; Chi S; Feng D; Wang H
Oncol Rep; 2016 Jun; 35(6):3419-26. PubMed ID: 27109209
[TBL] [Abstract][Full Text] [Related]
5. S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis.
Sherbet GV; Lakshmi MS
Anticancer Res; 1998; 18(4A):2415-21. PubMed ID: 9703888
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53.
Berge G; Mælandsmo GM
Amino Acids; 2011 Oct; 41(4):863-73. PubMed ID: 20177948
[TBL] [Abstract][Full Text] [Related]
7. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
8. Metastasis Promoter S100A4 is a Potential Molecular Therapeutic Target.
Sherbet GV
Cancer Genomics Proteomics; 2006; 3(3-4):203-216. PubMed ID: 31394699
[TBL] [Abstract][Full Text] [Related]
9. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
[TBL] [Abstract][Full Text] [Related]
10. S100A4 participates in epithelial-mesenchymal transition in breast cancer via targeting MMP2.
Xu H; Li M; Zhou Y; Wang F; Li X; Wang L; Fan Q
Tumour Biol; 2016 Mar; 37(3):2925-32. PubMed ID: 26409452
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression.
Techasen A; Namwat N; Loilome W; Duangkumpha K; Puapairoj A; Saya H; Yongvanit P
J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):703-11. PubMed ID: 24867797
[TBL] [Abstract][Full Text] [Related]
12. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
13. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma.
Zou M; Al-Baradie RS; Al-Hindi H; Farid NR; Shi Y
Br J Cancer; 2005 Nov; 93(11):1277-84. PubMed ID: 16265347
[TBL] [Abstract][Full Text] [Related]
14. S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?
Schneider M; Hansen JL; Sheikh SP
J Mol Med (Berl); 2008 May; 86(5):507-22. PubMed ID: 18322670
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the epithelial to mesenchymal transition markers S100A4, vimentin and Snail1 in gastroesophageal junction tumors.
Mirza A; Foster L; Valentine H; Welch I; West CM; Pritchard S
Dis Esophagus; 2014 Jul; 27(5):485-92. PubMed ID: 23082947
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G; Li M; Jin J; Bai Y; Yang C
Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
[TBL] [Abstract][Full Text] [Related]
18. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.
Herwig N; Belter B; Wolf S; Haase-Kohn C; Pietzsch J
J Cell Mol Med; 2016 May; 20(5):825-35. PubMed ID: 26928771
[TBL] [Abstract][Full Text] [Related]
19. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
[TBL] [Abstract][Full Text] [Related]
20. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N
BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
